(Updated - February 15, 2023 8:54 AM EST)

Jefferies analyst Dennis Ding downgraded Corcept Therapeutics (NASDAQ: CORT) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE